Premium
Review article: the use of potentially hepatotoxic drugs in patients with liver disease
Author(s) -
GUPTA N. K.,
LEWIS J. H.
Publication year - 2008
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/j.1365-2036.2008.03822.x
Subject(s) - medicine , chronic liver disease , liver disease , cirrhosis , drug , disease , medical prescription , intensive care medicine , chronic hepatitis , liver injury , pharmacology , immunology , virus
Summary Background Misconceptions surround the use of hepatotoxic drugs in chronic liver disease. While many prescription and over‐the‐counter (OTC) agents can be used safely, this often runs counter to labelled warnings/contraindications, especially for the statins and other commonly used agents. Aim To evaluate published data on the use of hepatotoxic drugs in chronic liver disease including pharmacokinetic changes in cirrhosis and drug interactions, where available, to formulate recommendations on their use. Methods Using a combination of PubMed searches, review texts, the Physicians’ Desk Reference and expert opinion, drugs considered at higher risk of hepatotoxicity in chronic liver disease were evaluated. Results Most drugs and OTC products including herbals have not been formally studied in chronic liver disease, but available data suggest that several of the most commonly used agents, especially the statins, can be used safely. While there is an increased risk of drug‐induced liver injury for drugs used in the treatment of tuberculosis and HIV patients with hepatitis B or C, recommendations for their safe use are emerging. Conclusions Although many clinicians remain hesitant to use hepatotoxic drugs in chronic liver disease, the database supporting this view is limited to just a few agents. Most medications can be used safely in patients with chronic liver disease with appropriate monitoring.